These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 14675605)

  • 1. Effects of antineuronal antibodies from patients with paraneoplastic neurological syndrome on primary-cultured neurons.
    Tanaka K; Ding X; Tanaka M
    J Neurol Sci; 2004 Jan; 217(1):25-30. PubMed ID: 14675605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of non-neuronal auto-antibodies in patients with anti-Hu or anti-Yo paraneoplastic diseases.
    Aguirre-Cruz L; Charuel JL; Carpentier AF; Benyahia B; Delattre JY; Musset L
    J Neurooncol; 2005 Jan; 71(1):39-41. PubMed ID: 15719273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic neurological syndromes associated with Yo, Hu, and Ri autoantibodies.
    Bradwell AR
    Clin Rev Allergy Immunol; 2000 Aug; 19(1):19-29. PubMed ID: 11064823
    [No Abstract]   [Full Text] [Related]  

  • 4. [A study on pathomechanisms of paraneoplastic neurological syndrome].
    Tanaka K
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1150-2. PubMed ID: 12235823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies.
    Uchuya M; Graus F; Vega F; Reñé R; Delattre JY
    J Neurol Neurosurg Psychiatry; 1996 Apr; 60(4):388-92. PubMed ID: 8774401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disturbance in the serum IgG subclass distribution in patients with anti-Hu positive paraneoplastic neurological syndromes.
    Blaes F; Klotz M; Funke D; Strittmatter M; Kraus J; Kaps M
    Eur J Neurol; 2002 Jul; 9(4):369-72. PubMed ID: 12099920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenesis of paraneoplastic neurological syndromes].
    Tanaka K
    Brain Nerve; 2010 Apr; 62(4):309-18. PubMed ID: 20420170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal uptake of anti-Hu antibody, but not anti-Ri antibody, leads to cell death in brain slice cultures.
    Greenlee JE; Clawson SA; Hill KE; Wood B; Clardy SL; Tsunoda I; Jaskowski TD; Carlson NG
    J Neuroinflammation; 2014 Sep; 11():160. PubMed ID: 25228406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onconeuronal and antineuronal antibodies in patients with neoplastic and non-neoplastic pulmonary pathologies and suspected for paraneoplastic neurological syndrome.
    Michalak S; Cofta S; Piatek A; Rybacka J; Wysocka E; Kozubski W
    Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):156-61. PubMed ID: 20156748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraneoplastic antibody during follow-up of a patient with anti-Ri-associated paraneoplastic neurological syndrome.
    Stich O; Rasiah C; Rauer S
    Acta Neurol Scand; 2009 May; 119(5):338-40. PubMed ID: 18822086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraneoplastic antineuronal antibodies in patients with systemic autoimmune diseases.
    Benyahia B; Amoura Z; Rousseau A; Le Clanche C; Carpentier A; Piette JC; Delattre JY
    J Neurooncol; 2003 May; 62(3):349-51. PubMed ID: 12777089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autoantibodies in Paraneoplastic Neurological Syndrome].
    Kawachi I
    Brain Nerve; 2018 Apr; 70(4):329-339. PubMed ID: 29632281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor progression and serum anti-HuD antibody concentration in patients with paraneoplastic neurological syndromes.
    Rauer S; Andreou I
    Eur Neurol; 2002; 47(4):189-95. PubMed ID: 12037430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplex serology of paraneoplastic antineuronal antibodies.
    Maat P; Brouwer E; Hulsenboom E; VanDuijn M; Schreurs MW; Hooijkaas H; Smitt PA
    J Immunol Methods; 2013 May; 391(1-2):125-32. PubMed ID: 23500780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spectrum of antineuronal autoantibodies in a series of neurological patients.
    Vianello M; Vitaliani R; Pezzani R; Nicolao P; Betterle C; Keir G; Thompson EJ; Tavolato B; Scaravilli F; Giometto B
    J Neurol Sci; 2004 May; 220(1-2):29-36. PubMed ID: 15140602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restricted IgG1 subclass of anti-Yo antibodies in paraneoplastic cerebellar degeneration.
    Amyes E; Curnow J; Stark Z; Corlett L; Sutton I; Vincent A
    J Neuroimmunol; 2001 Mar; 114(1-2):259-64. PubMed ID: 11240040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of circulating anti-Hu antibody in serial samples from patients with paraneoplastic neurological syndromes: possible correlation of antibody concentration and course of neurological symptoms.
    Rauer S; Czygan M; Kaiser R
    J Neurol; 2002 Mar; 249(3):285-9. PubMed ID: 11993527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological mechanisms in paraneoplastic peripheral neuropathy.
    Antoine JC
    Clin Rev Allergy Immunol; 2000 Aug; 19(1):61-72. PubMed ID: 11064827
    [No Abstract]   [Full Text] [Related]  

  • 19. Autoantibodies in paraneoplastic neurological syndrome.
    Inuzuka T
    Am J Med Sci; 2000 Apr; 319(4):217-26. PubMed ID: 10768606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
    Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
    J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.